Home › Endometrial Cancer › California
Endometrial Cancer clinical trials in California
73 studies for Endometrial Cancer are looking for participants at sites in California.
Cities in California
- Los Angeles35 studies
- Baldwin Park17 studies
- San Francisco16 studies
- San Diego15 studies
- Mountain View12 studies
- Irvine10 studies
- Orange10 studies
- Santa Monica9 studies
- Sacramento7 studies
- Santa Rosa6 studies
- Newport Beach5 studies
- Concord3 studies
- Vallejo3 studies
A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- UCSF - Helen Diller Family Comprehensive Cancer Center, San Francisco
RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT07664735A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- The City of Hope National Medical Center, Duarte
- Hoag Memorial Hospital, Newport Beach
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Nov 12, 2026 · NCT07197554A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Cedars-Sinai Medical Center, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07458347Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- PCR Oncology, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- and 15 more
RecruitingPhase 2
All ages · All sexes · Updated Nov 12, 2026 · NCT05564377Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Cedars-Sinai Medical Center, Los Angeles
- Huntington Memorial Hospital, Pasadena
- Sutter Medical Center Sacramento, Sacramento
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT05640999A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- USC/Norris Cancer Center, Los Angeles
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT06340568A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Cedars-Sinai Medical Center, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07020221A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014), Irvine
- University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020), Orange
- Sansum Clinic (Ridley Tree) ( Site 8007), Solvang
- and 1 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT06952504A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- City of Hope Comprehensive Cancer Center, Duarte
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07503808Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- Kaiser Permanente Dublin, Dublin
- and 26 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 6, 2026 · NCT07198074A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Nov 5, 2026 · NCT06586957cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of California Los Angeles Medical Center, Los Angeles
- University of California, San Diego; Moores Cancer Center, San Diego
- USOR Sansum Clinic, Santa Barbara
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05579366A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06400472A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07114601Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- and 10 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06760819Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Kaiser Permanente SoCal, Irvine
- CPMC Research Institute, San Francisco
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 3, 2026 · NCT07166094Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- START Los Angeles, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07524322EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- California Research Institute (CRI), Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07262619A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Duarte
- City of Hope, Irvine, Irvine
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07109726A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06242470A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Los Angeles Cancer Network, Los Angeles
- Pih Health Hematology Medical Oncology, Whittier
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06330064A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06172478A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START Los Angeles, Los Angeles
- Stanford Cancer Center, Palo Alto
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07383506A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
- Providence Medical Foundation, Santa Rosa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT04657068A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- City of Hope at Arcadia, Arcadia
- City of Hope Medical Center, Duarte
- City of Hope at Seacliff, Huntington Beach
- and 8 more
Recruiting
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07741968Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT06293898A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05123482DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
- and 1 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 13, 2026 · NCT06989112Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT06993844Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- University of California, San Francisco, San Francisco
RecruitingPhase 1
Ages 18 and older · Women · Updated Oct 13, 2026 · NCT06795009Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- City of Hope, Duarte
- Stanford University, Palo Alto
- University of California San Francisco, San Francisco
RecruitingPhase 1
Ages 15 and older · All sexes · Updated Oct 9, 2026 · NCT06276491FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of California, Los Angeles (UCLA), Los Angeles
- Stanford Cancer Institute, Stanford University, Palo Alto
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Duarte
- Research Site, Irvine
RecruitingPhase 1/2
Ages 18 to 130 · All sexes · Updated Oct 5, 2026 · NCT05797168A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06840886The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750DESTINY-PANTUMOUR04
- Research Site, San Diego
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07229313A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- City of Hope Comprehensive Cancer Center, Duarte
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- Chao Family Comprehensive Cancer Center, Orange
RecruitingPhase 1/2
Ages 18 and older · Women · Updated Sep 24, 2026 · NCT04590326From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.